Skip to main content
. Author manuscript; available in PMC: 2014 Jun 3.
Published in final edited form as: Psychopharmacology (Berl). 2013 May 8;229(4):591–601. doi: 10.1007/s00213-013-3117-6

Fig. 5.

Fig. 5

CB2 receptors are not required for the expression of mecamylamine-precipitated withdrawal responses in nicotine-dependent mice. CB2 (−/−) and (+/+) mice implanted with nicotine mini pumps and challenged with mecamylamine (2 mg/kg, s.c.) displayed similar: a anxiogenic-like responses, as reflected by a pronounced decrease of time spent in the open arms of elevated plus maze test, b total number of somatic withdrawal signs, and c hyperalgesic responses in the hot plate test. Data are depicted as mean± SEM, n=6 per group; ***p<0.001 vs saline for each respective genotype